Thu, April 26, 2018
Wed, April 25, 2018
Tue, April 24, 2018

Matthew Harrison Maintained (AMGN) at Buy with Decreased Target to $200 on, Apr 25th, 2018

Matthew Harrison of Morgan Stanley, Maintained "Amgen Inc." (AMGN) at Buy with Decreased Target from $205 to $200 on, Apr 25th, 2018.

Matthew has made no other calls on AMGN in the last 4 months.



There are 7 other peers that have a rating on AMGN. Out of the 7 peers that are also analyzing AMGN, 5 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Maintained at Hold with Decreased Target to $180 on, Thursday, April 5th, 2018
  • Steve Chesney of "Atlantic Equities" Downgraded from Buy to Hold on, Monday, February 5th, 2018
  • Ian Somaiya of "BMO Capital" Maintained at Hold with Increased Target to $202 on, Friday, February 2nd, 2018
  • Alethia Young of "Credit Suisse" Maintained at Hold with Increased Target to $194 on, Friday, February 2nd, 2018
  • Cory Kasimov of "JP Morgan" Maintained at Hold with Increased Target to $189 on, Wednesday, January 24th, 2018


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $190 on, Friday, February 2nd, 2018
  • David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $220 on, Tuesday, January 23rd, 2018